Hoppa till innehåll
Tillbaka till artiklar
guide4 min läsning

Tirzepatide Guide 2025: Dual GLP-1/GIP Agonist

Tirzepatide is the first approved dual GLP-1/GIP agonist for weight loss. This guide covers how to buy Tirzepatide in Europe, explores dosage recommendations, and compares it to Semaglutide, providing insights into its potential as a Mounjaro alternative.

26 januari 2026Redaktionen
Tirzepatide Guide 2025: Dual GLP-1/GIP Agonist
```html

What is Tirzepatide?

Tirzepatide (marketed as Mounjaro for diabetes and Zepbound for weight loss) is a dual GLP-1/GIP receptor agonist developed by Eli Lilly.

🧬 Dual Mechanism of Action

Unlike Semaglutide, which only activates GLP-1, Tirzepatide activates two receptors:

  • GLP-1 — Glucagon-like peptide-1 (same as Semaglutide)
  • GIP — Glucose-dependent insulinotropic polypeptide

This dual action potentially provides better results than GLP-1 activation alone.

How does Tirzepatide work?

GLP-1 Effects:

  • Reduces appetite by acting on the brain
  • Slows gastric emptying
  • Increases insulin release when blood sugar is high
  • Decreases glucagon production

✨ GIP Effects (unique to Tirzepatide)

  • Enhances insulin sensitivity
  • May contribute to increased energy expenditure
  • Potentially reduced side effects compared to GLP-1 alone
  • Improved adipose tissue function

Clinical Results

The SURMOUNT studies showed impressive results:

Dosage Weight Loss (72 weeks) Comment
5 mg ~15% Lowest maintenance dose
10 mg ~20% Common effective dose
15 mg ~22% Maximum dose

📊 SURPASS Studies (Diabetes)

  • Better blood sugar control than Semaglutide
  • More patients achieved normal HbA1c

Tirzepatide Dosage

⚠️ Important

Always follow the titration schedule to minimize side effects. Never start at full dose!

Week 1-4 2.5 mg Starting dose — Acclimatization
Week 5-8 5 mg First increase
Week 9-12 7.5 mg Intermediate dose
Week 13-16 10 mg Standard dose — Many stop here
Week 17-20 12.5 mg Increased dose
Week 21+ 15 mg Maximum dose

💡 Tips

Not everyone needs to reach the maximum dose. Many achieve excellent results at 10 mg.

Tirzepatide vs Semaglutide

Feature Tirzepatide Semaglutide
Receptors GLP-1 + GIP Only GLP-1
Weight Loss ~20-22% ~15-17%
Approved Since 2022-2023 2017-2021
Side Effects Slightly lower frequency Well-documented
Safety Data Shorter history Longer history

📖 Read full comparison →

Side Effects of Tirzepatide

The side effect profile is similar to Semaglutide but with a slightly lower frequency:

Side Effect Frequency
Nausea ~35%
Diarrhea ~25%
Constipation ~20%
Vomiting ~15%

Less Common:

  • Abdominal pain
  • Headache
  • Fatigue
  • Injection site reactions

✓ Good News

Most side effects subside after the initial weeks of titration.

Who is Tirzepatide Suitable For?

✓ Good Candidates

  • Individuals who have not achieved sufficient results with Semaglutide
  • Type 2 diabetics looking to lose weight
  • Those seeking a stronger weight loss effect
  • Individuals who tolerate GLP-1 treatment well

⚠️ Caution with:

  • History of pancreatitis
  • Severely impaired kidney function
  • Family history of medullary thyroid cancer
  • Pregnancy/breastfeeding

Storage of Tirzepatide

Condition Temperature Shelf Life
Unopened 2-8°C (refrigerator) As per packaging
Reconstituted 2-8°C (refrigerator) Max 28 days
Room Temperature Below 25°C Max 21 days

🚫 Never Freeze!

Freezing permanently destroys the peptide structure.

Mixing Tirzepatide

The same principles as for Semaglutide:

  1. Let the peptide reach room temperature — Avoid condensation
  2. Clean the rubber stopper — With an alcohol wipe
  3. Add BAC water along the glass wall — Never inject directly onto the powder
  4. Gently swirl — Never shake!
  5. Store in the refrigerator — Label with date

📖 Read detailed mixing guide →

Frequently Asked Questions about Tirzepatide

Is Tirzepatide better than Semaglutide?

Tirzepatide shows better weight loss results in studies. However, Semaglutide has longer safety data.

Can I switch from Semaglutide to Tirzepatide?

Yes, you start at the initial dose of Tirzepatide (2.5 mg) and titrate according to the schedule.

How long do you need to take Tirzepatide?

As with all GLP-1-based treatments, long-term use is often necessary to maintain weight loss.


Summary

✓ Tirzepatide in Brief

Tirzepatide represents a significant advancement in the treatment of overweight and obesity. With its dual mechanism of action, it provides:

  • Better weight loss results — than Semaglutide
  • Potentially lower frequency of side effects
  • Improved blood sugar control

For those seeking maximum efficacy among approved treatments, Tirzepatide is often the best choice.

⚠️ Research Disclaimer

All peptides we sell are intended for research purposes only. Always consult a physician before starting any treatment.

📖 Read the Semaglutide Guide →

📖 Read the Retatrutide Guide →

```
tirzepatidemounjarozepboundglp-1gipviktminskning

Ready to get started?

Explore our range of high-quality GLP-1 peptides with fast delivery across Europe.

View all products